Peregrine Capital Management’s CME Group CME Stock Holding History

Peregrine Capital Management’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-77,782	Closed	-$13.4M	–	302
2020 Q1	$13.4M	Sell	77,782 -6,443	-8%	-$1.28M	0.48%	83
2019 Q4	$16.9M	Buy	84,225 +323	+0.4%	+$66.3K	0.43%	103
2019 Q3	$17.7M	Sell	83,902 -10,186	-11%	-$2.13M	0.48%	87
2019 Q2	$18.3M	Sell	94,088 -10	-0%	-$1.84K	0.45%	91
2019 Q1	$15.5M	Buy	94,098 +1,114	+1%	+$197K	0.39%	117
2018 Q4	$17.5M	Buy	92,984 +2,267	+2%	+$419K	0.49%	74
2018 Q3	$15.4M	Hold	90,717	–	–	0.37%	125
2018 Q2	$14.9M	Buy	90,717 +277	+0.3%	+$45.2K	0.37%	120
2018 Q1	$14.6M	Sell	90,440 -338	-0.4%	-$53.8K	0.36%	118
2017 Q4	$13.3M	Hold	90,778	–	–	0.31%	126
2017 Q3	$12.3M	Hold	90,778	–	–	0.3%	134
2017 Q2	$11.4M	Hold	90,778	–	–	0.28%	146
2017 Q1	$10.8M	Sell	90,778 -45,246	-33%	-$5.44M	0.27%	142
2016 Q4	$15.7M	Buy	136,024 +11,190	+9%	+$1.25M	0.41%	90
2016 Q3	$13M	Buy	+124,834	New	+$13M	0.34%	124

Other funds holding CME

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Peregrine Capital Management's CME Position: Q2 2020 in Review

Peregrine Capital Management sold out of CME Group (CME) in Q2 2020, closing a stake of 77,782 shares — an estimated $13.4M sold.

Peregrine Capital Management first reported a position in CME in Q3 2016 and held it in 15 quarters. The position peaked at $18.3M in Q2 2019. 1,045 funds tracked by Wall St. Rank hold CME as of Q2 2020.

Peregrine Capital Management reported no remaining CME Group position as of Q2 2020 after selling out during the quarter.
Peregrine Capital Management sold 77,782 CME Group shares in Q2 2020, an estimated $13.4M.
Peregrine Capital Management first reported a position in CME Group in Q3 2016 and held it in 15 quarters.
Peregrine Capital Management's CME Group position peaked at $18.3M in Q2 2019.
1,045 funds tracked by Wall St. Rank held CME Group as of Q2 2020.

Based on Peregrine Capital Management's 13F filing for Q2 2020, filed 30 Jul 2020.